On October 21st, Sanofi announced it has entered into exclusive negotiations with CD&R to sell a controlling stake in Opella. This announcement is a major and exciting milestone on our …

Oct 30, 2024 · Sanofi announced that it has entered into exclusive negotiations with the US private equity firm Clayton, Dubilier & Rice (CD&R) to transfer around 50% controlling stake in …

Learn about Opella's brands such as Buscopan, Icy Hot, and Dulcolax that are helping more people champion better self-care.

Learn about Opella's commitment to make health better by empowering people to champion self-care. Discover our actions and our values today.

Oct 21, 2024 · French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm …

3 days ago · Opella employs more than 11,000 people worldwide and is known for making Doliprane, one of France’s most-sold paracetamol-based painkillers. The medicine is so …

4 days ago · Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed the share purchase agreement in relation to the sale …

Oct 21, 2024 · Opella with Sanofi to remain a significant shareholder • With 11,000 talented and passionate people bringing iconic brands to life, Opella poised to ignite new bold development …

Oct 21, 2005 · Partnering with CD&R will allow Opella to unlock its full development potential, to further drive value creation and deploy the exceptional talent of our teams to become a leading …

3 days ago · Sanofi and CD&R sign Opella share purchase agreement. Paris, February 19, 2025.Following completion of the required social and corporate procedures, Sanofi and CD&R …